quinazolines has been researched along with Sicca Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Xiang, J; Zhang, C | 1 |
| Asashima, H; Hirota, T; Kondo, Y; Matsumoto, I; Moriyama, M; Nakamura, S; Sumida, T; Takahashi, H; Tsuboi, H | 1 |
2 other study(ies) available for quinazolines and Sicca Syndrome
| Article | Year |
|---|---|
When EGFR inhibitor meets autoimmune disease: Severe corneal complications in a patient with Sjögren syndrome after erlotinib treatment.
Topics: Cornea; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Quinazolines; Sjogren's Syndrome | 2022 |
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
Topics: Active Transport, Cell Nucleus; Adult; Aged; beta Karyopherins; Cell Differentiation; Cells, Cultured; DNA, Complementary; Female; Gene Expression Profiling; Humans; Immune System Diseases; Immunoglobulin G; Interleukins; Middle Aged; Nuclear Receptor Subfamily 4, Group A, Member 2; Quinazolines; Salivary Glands; Sjogren's Syndrome; Th17 Cells; Tissue Array Analysis | 2017 |